Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP

被引:206
|
作者
Haque, M. Emdadul [1 ]
Thomas, Kelly J. [2 ]
D'Souza, Cheryl [4 ]
Callaghan, Steve [1 ]
Kitada, Tohru [3 ]
Slack, Ruth S. [1 ]
Fraser, Paul [4 ]
Cookson, Mark R. [2 ]
Tandon, Anurag [4 ]
Park, David S. [1 ]
机构
[1] Univ Ottawa, Neurosci Grp, Ottawa Hlth Res Inst, Ottawa, ON K1H 8M5, Canada
[2] NIA, Neurogenet Lab, Bethesda, MD 20892 USA
[3] Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA
[4] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada
关键词
Parkinson's disease; neurodegeneration; neuroprotection;
D O I
10.1073/pnas.0705363105
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
PTEN-induced putative kinase 1 (Pink1) is a recently identified gene linked to a recessive form of familial Parkinson's disease (PD). The kinase contains a mitochondrial localization sequence and is reported to reside, at least in part, in mitochondria. However, neither the manner by which the loss of Pink1 contributes to dopamine neuron loss nor its impact on mitochondrial function and relevance to death is clear. Here, we report that depletion of Pink1 by RNAi increased neuronal toxicity induced by MPP+. Moreover, wild-type Pink1, but not the G309D mutant linked to familial PD or an engineered kinase-dead mutant K219M, protects neurons against MPTP both in vitro and in vivo. Intriguingly, a mutant that contains a deletion of the putative mitochondrial-targeting motif was targeted to the cytoplasm but still provided protection against 1-methyl-4-phenylpyridine (MPP+)/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced toxicity. In addition, we also show that endogenous Pink1 is localized to cytosolic as well as mitochondrial fractions. Thus, our findings indicate that Pink1 plays a functional role in the survival of neurons and that cytoplasmic targets, in addition to its other actions in the mitochondria, may be important for this protective effect.
引用
收藏
页码:1716 / 1721
页数:6
相关论文
共 50 条
  • [1] Salidroside Protects Dopaminergic Neurons by Enhancing PINK1/Parkin-Mediated Mitophagy
    Li, Ruru
    Chen, Jianzong
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2019, 2019
  • [2] Dopaminergic cell damage and vulnerability to MPTP in Pink1 knockdown zebrafish
    Sallinen, Ville
    Kolehmainen, Juha
    Priyadarshini, Madhusmita
    Toleikyte, Gabija
    Chen, Yu-Chia
    Panula, Pertti
    NEUROBIOLOGY OF DISEASE, 2010, 40 (01) : 93 - 101
  • [3] PINK1 deficiency impairs adult neurogenesis of dopaminergic neurons
    Brown, Sarah J.
    Boussaad, Ibrahim
    Jarazo, Javier
    Fitzgerald, Julia C.
    Antony, Paul
    Keatinge, Marcus
    Blechman, Janna
    Schwamborn, Jens C.
    Krueger, Rejko
    Placzek, Marysia
    Bandmann, Oliver
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [4] PINK1 and Parkin complementarily protect dopaminergic neurons in vertebrates
    Matsui, Hideaki
    Gavinio, Roberto
    Asano, Takeshi
    Uemura, Norihito
    Ito, Hidefumi
    Taniguchi, Yoshihito
    Kobayashi, Yoshito
    Maki, Takakuni
    Shen, Jie
    Takeda, Shunichi
    Uemura, Kengo
    Yamakado, Hodaka
    Takahashi, Ryosuke
    HUMAN MOLECULAR GENETICS, 2013, 22 (12) : 2423 - 2434
  • [5] PINK1 deficiency impairs adult neurogenesis of dopaminergic neurons
    Sarah J. Brown
    Ibrahim Boussaad
    Javier Jarazo
    Julia C. Fitzgerald
    Paul Antony
    Marcus Keatinge
    Janna Blechman
    Jens C. Schwamborn
    Rejko Krüger
    Marysia Placzek
    Oliver Bandmann
    Scientific Reports, 11
  • [6] Pink1 regulates FKBP5 interaction with AKT/PHLPP and protects neurons from neurotoxin stress induced by MPP+
    Boonying, Wassamon
    Joselin, Alvin
    Huangt, En
    Qu, Dianbo
    Safarpour, Farzaneh
    Iyirhiaro, Grace O.
    Gonzalez, Yasmilde Rodriguez
    Callaghan, Steve M.
    Slack, Ruth S.
    Figeys, Daniel
    Chung, Young-Hwa
    Park, David S.
    JOURNAL OF NEUROCHEMISTRY, 2019, 150 (03) : 312 - 329
  • [7] Characterization of PINK1 mutant iPS cell-derived dopaminergic neurons
    Seibler, P.
    Krainc, D.
    Moser, A.
    Terlau, H.
    Klein, C.
    MOVEMENT DISORDERS, 2012, 27 : S468 - S469
  • [8] Generation of a cellular model of PINK1 parkinsonism in primary human dopaminergic neurons
    Wood-Kaczmar, A.
    Gandhi, S.
    Jat, P.
    Miljan, E. A.
    Sinden, J.
    Keen, G. J.
    Taylor, J.
    Latchman, D. S.
    Wood, N. W.
    Tabrizi, S. J.
    MOVEMENT DISORDERS, 2006, 21 : S546 - S546
  • [9] PINK1 function in the nigrostriatal dopaminergic system
    Kitada, T.
    Pisani, A.
    Porter, D. R.
    Yamaguchi, H.
    Tscherter, A.
    Martella, G.
    Bonsi, P.
    Pothos, E. N.
    Shen, J.
    MOVEMENT DISORDERS, 2006, 21 : S587 - S587
  • [10] PINK1 Is Necessary for Long Term Survival and Mitochondrial Function in Human Dopaminergic Neurons
    Wood-Kaczmar, Alison
    Gandhi, Sonia
    Yao, Zhi
    Abramov, Andrey S. Y.
    Miljan, Erik A.
    Keen, Gregory
    Stanyer, Lee
    Hargreaves, Iain
    Klupsch, Kristina
    Deas, Emma
    Downward, Julian
    Mansfield, Louise
    Jat, Parmjit
    Taylor, Joanne
    Heales, Simon
    Duchen, Michael R.
    Latchman, David
    Tabrizi, Sarah J.
    Wood, Nicholas W.
    PLOS ONE, 2008, 3 (06):